Leaflet NAAXIA 38mg / ml ophthalmic solution


Indicated for: allergic conjunctivitis

Route of administration: ophthalmic

Substance: spaglumic acid (antiallergic agent)

ATC: S01GX03 (Sensory organs | Decongestants and antiallergics | Other antiallergics)

Spaglumic acid is a compound used in the treatment of certain gastrointestinal conditions, such as irritable bowel syndrome and functional dyspepsia. It has antispasmodic and anti-inflammatory properties.

It is administered orally, usually in the form of capsules or tablets, and helps reduce abdominal pain and discomfort associated with intestinal spasms. It may also improve bowel transit.

Side effects are rare but may include nausea, dizziness, or allergic reactions. It is important for patients to follow the recommended dosage to avoid potential adverse effects.

Spaglumic acid is contraindicated in patients with known hypersensitivity to the substance or any of the excipients in the medication.

General data about NAAXIA 38mg / ml

  • Substance: spaglumic acid
  • Date of last drug list: 01-07-2013
  • Commercial code: W13108001
  • Concentration: 38mg / ml
  • Pharmaceutical form: ophthalmic solution
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.